BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Janicko M, Drazilova S, Pella D, Fedacko J, Jarcuska P. Pleiotropic effects of statins in the diseases of the liver. World J Gastroenterol 2016; 22(27): 6201-6213 [PMID: 27468210 DOI: 10.3748/wjg.v22.i27.6201]
URL: https://www.wjgnet.com/1007-9327/full/v22/i27/6201.htm
Number Citing Articles
1
Sean Sileno, Razvan M. Chirila, Dana M. Harris. Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general cliniciansRomanian Journal of Internal Medicine 2020; 58(4): 181 doi: 10.2478/rjim-2020-0018
2
Christa Buechler, Charalampos Aslanidis. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(5): 158658 doi: 10.1016/j.bbalip.2020.158658
3
Tawfik Khoury, Amir Mari, Hana Amara, Mohamed Jabaren, Abdulla Watad, Wiliam Nseir, Wisam Sbeit, Mahmud Mahamid. Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux DiseaseCanadian Journal of Gastroenterology and Hepatology 2019; 2019: 1 doi: 10.1155/2019/6415757
4
Chalermrat Bunchorntavakul, K. Rajender Reddy. Pharmacologic Management of Portal HypertensionClinics in Liver Disease 2019; 23(4): 713 doi: 10.1016/j.cld.2019.06.004
5
Niki Katsiki, Vasilios G Athyros. Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatmentCurrent Medical Research and Opinion 2019; 35(7): 1305 doi: 10.1080/03007995.2019.1589152
6
H. A. Elmekawy, F. Belal, A. E. Abdelaziz, K. S. Abdelkawy, A. A. Ali, F. Elbarbry. Pharmacokinetic interaction between atorvastatin and fixed-dose combination of sofosbuvir/ledipasvir in healthy male Egyptian volunteersEuropean Journal of Clinical Pharmacology 2021; 77(9): 1369 doi: 10.1007/s00228-021-03130-z
7
V. Ye. Molodtsov, O. I. Fediv, G. Ya. Stupnytska. ЕФЕКТИВНІСТЬ ЗАСТОСУВАННЯ АТОРВАСТАТИНУ ПРИ ПОЄДНАННІ АЛКОГОЛЬНОЇ ХВОРОБИ ПЕЧІНКИ ТА АРТЕРІАЛЬНОЇ ГІПЕРТЕНЗІЇЗдобутки клінічної і експериментальної медицини 2020; (2): 126 doi: 10.11603/1811-2471.2020.v.i2.11188
8
Abdolkhaleg Deezagi, Naser Safari. Rosuvastatin inhibit spheroid formation and epithelial–mesenchymal transition (EMT) in prostate cancer PC-3 cell lineMolecular Biology Reports 2020; 47(11): 8727 doi: 10.1007/s11033-020-05918-1
9
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA TherapyCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
10
Peter Jarcuska, Ahmed Abdel-Razik, Robert Flisiak, Ram B. Singh. Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular RiskCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/7369314
11
Narendra S. Choudhary, Sanjiv Saigal, Neeraj Saraf, Arvinder S. Soin. Acute Onset Significant Muscle Weakness in a Patient Awaiting Liver Transplantation: Look for StatinsJournal of Clinical and Experimental Hepatology 2017; 7(1): 66 doi: 10.1016/j.jceh.2016.09.007
12
Ruirui Feng, Xiaozhong Guo, Yun Kou, Xiangbo Xu, Cen Hong, Wenwen Zhang, Yang An, Cyriac Abby Philips, Andrea Mancuso, Xingshun Qi. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosisPostgraduate Medicine 2021; 133(6): 626 doi: 10.1080/00325481.2021.1930560
13
Pamela Tietz-Bogert, Minsuk Kim, Angela Cheung, James Tabibian, Julie Heimbach, Charles Rosen, Madhumitha Nandakumar, Konstantinos Lazaridis, Nicholas LaRusso, Jaeyun Sung, Steven O’Hara. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing CholangitisInternational Journal of Molecular Sciences 2018; 19(10): 3188 doi: 10.3390/ijms19103188
14
Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, Alberto Mondelli, Serena Bursi, Giovanna Onfiani, Francesca Carubbi, Amedeo Lonardo. Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foesAtherosclerosis 2019; 284: 66 doi: 10.1016/j.atherosclerosis.2019.02.028
15
Stuart McPherson, Shion Gosrani, Sarah Hogg, Preya Patel, Aaron Wetten, Rachael Welton, Kate Hallsworth, Matthew Campbell. Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis CBMJ Open Gastroenterology 2020; 7(1): e000470 doi: 10.1136/bmjgast-2020-000470
16
Hui Li. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinomaDigestive and Liver Disease 2021;  doi: 10.1016/j.dld.2021.07.006
17
Urša Kovač, Cene Skubic, Laura Bohinc, Damjana Rozman, Tadeja Režen. Oxysterols and Gastrointestinal Cancers Around the ClockFrontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00483
18
Yi-Hao Yen, Kwong-Ming Kee, Chien-Hung Chen, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Tatsuo Kanda. Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis CPLOS ONE 2019; 14(1): e0208858 doi: 10.1371/journal.pone.0208858
19
Francisco J. Zapatero-Belinchón, Rina Ötjengerdes, Julie Sheldon, Benjamin Schulte, Belén Carriquí-Madroñal, Graham Brogden, Laura M. Arroyo-Fernández, Florian W. R. Vondran, Benjamin Maasoumy, Thomas von Hahn, Gisa Gerold. Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV InfectivityCells 2021; 10(7): 1626 doi: 10.3390/cells10071626
20
Yue Chang, Qinyu Liu, Zidong Zhou, Yuping Ding, Mei Yang, Wei Xu, Kai Chen, Qing Zhang, Zhenguo Wang, Hai Li. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-AnalysisTechnology in Cancer Research & Treatment 2020; 19: 153303382093488 doi: 10.1177/1533033820934881
21
Yi-Hsuan Wei, Shu-Lang Liao, Sen-Hsu Wang, Chia-Chun Wang, Chang-Hao Yang. Simvastatin and ROCK Inhibitor Y-27632 Inhibit Myofibroblast Differentiation of Graves’ Ophthalmopathy-Derived Orbital Fibroblasts via RhoA-Mediated ERK and p38 Signaling PathwaysFrontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.607968
22
Christopher Kasia, Steven J. Scaglione. Patients With Chronic Liver Disease/Cirrhosis Should Not Take Statin MedicationsClinical Liver Disease 2019; 13(4): 106 doi: 10.1002/cld.788
23
Dominik Safcak, Sylvia Drazilova, Jakub Gazda, Igor Andrasina, Svetlana Adamcova-Selcanova, Radovan Barila, Michal Mego, Marek Rac, Lubomir Skladany, Miroslav Zigrai, Martin Janicko, Peter Jarcuska. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival—A Retrospective Analysis of a Slovak CohortJournal of Clinical Medicine 2021; 10(14): 3186 doi: 10.3390/jcm10143186
24
Sneha Kothari, Hiteshi Dhami-Shah, Samir R. Shah. Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Experimental Hepatology 2019; 9(6): 723 doi: 10.1016/j.jceh.2019.06.003
25
Antonio Magan-Fernandez, Manfredi Rizzo, Giuseppe Montalto, Giulio Marchesini. Statins in liver disease: not only prevention of cardiovascular eventsExpert Review of Gastroenterology & Hepatology 2018; 12(8): 743 doi: 10.1080/17474124.2018.1477588
26
Daniela M. Santos, Lorena Pantano, Gina Pronzati, Paula Grasberger, Clemens K. Probst, Katharine E. Black, Jillian J. Spinney, Lida P. Hariri, Royale Nichols, Yufei Lin, Michael Bieler, Peter Seither, Paul Nicklin, David Wyatt, Andrew M. Tager, Benjamin D. Medoff. Screening for YAP Inhibitors Identifies Statins as Modulators of FibrosisAmerican Journal of Respiratory Cell and Molecular Biology 2020; 62(4): 479 doi: 10.1165/rcmb.2019-0296OC
27
Armita M. Gorabi, Nasim Kiaie, Vanessa Bianconi, Tannaz Jamialahmadi, Khalid Al-Rasadi, Thomas P. Johnston, Matteo Pirro, Amirhossein Sahebkar. Antiviral effects of statinsProgress in Lipid Research 2020; 79: 101054 doi: 10.1016/j.plipres.2020.101054
28
Mazaher Ahmadi, Shayan Amiri, Stevan Pecic, Filip Machaj, Jakub Rosik, Marek J. Łos, Javad Alizadeh, Reza Mahdian, Simone C. da Silva Rosa, Dedmer Schaafsma, Shahla Shojaei, Tayyebeh Madrakian, Amir A. Zeki, Saeid Ghavami. Pleiotropic effects of statins: A focus on cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(12): 165968 doi: 10.1016/j.bbadis.2020.165968
29
SK Jha, K Saharawat, R Keshari, P Jha, S Purkayastha, R Ranjan. Addition of Simvastatin to Carvedilol and Endoscopic Variceal Ligation improves rebleeding and survival in patients with Child-Pugh A and B class but not in Child Pugh C classAnnals of Clinical Gastroenterology and Hepatology 2019; 3(1): 020 doi: 10.29328/journal.acgh.1001010